Covid-19 Mass Vaccination Plan | Vaccines | Public Health

Uploaded by

100% (1) 100% found this document useful (1 vote)

4K views

95 pages

Description:

covid vax plan

Date uploaded

Oct 19, 2020

Copyright

© © All Rights Reserved

Available Formats

PDF, TXT or read online from Scribd

Share this document

Did you find this document useful?

Is this content inappropriate?

Report this Document

100% (1) 100% found this document useful (1 vote)

4K views 95 pages

Uploaded by

Description:

covid vax plan

Full description Jump to Page You are on page 1 of 95 Search inside document

1

INTERIM DRAFT

NORTH DAKOTA COVID-19 VACCINATION PLAN

Updated October 16, 2020 Version 1.2

2

Contents

Acronyms ......................................................................................................................................................... 6 Introduction .................................................................................................................................................... 7 Lessons Learned from H1N1 ................................................................................................................ 8 Response Goals for Pandemic Vaccination ................................................................................... 10 COVID-19 Mass Vaccination Planning Assumptions ............ ............. ............. ............. ............. . 11 Logistical Assumptions ......................................................................................................................... 12 Organizational Structure and Partner Involvement ................................................................... 13 Unified Command Planning Team ............................................................................................... 14 Internal COVID-19 Vaccination Planning Team ...................................................................... 14 Internal/External COVID-19 Vaccination Planning Committee ............ ............. ............. ... 14 CDC/HHS Microplanning ................................................................................................................ 14 Tabletop Exercises ............................................................................................................................. 15 Current Unknowns and Contingency Planning ........................................................................... 15 How persons who have tested positive for C OVID-19 will be prioritized. ............. ....... 15 Type of vaccine that will be available and cold chain requirements of vaccines. ....... 15 Potential adverse effects of a vaccine. ....................................................................................... 16 Vaccine amounts. ............................................................................................................................... 16 Vaccine Timing. ................................................................................................................................... 16 Use of adjuvant. .................................................................................................................................. 16 Multiple FDA approved products with different specifications. ..................... ............. ..... 17 Packaging. ............................................................................................................................................. 17 Current Significant Gaps ...................................................................................................................... 17 Provider Recruitment and Enrollment ................................................................................................. 19 Potential Providers ................................................................................................................................. 22 Vaccine Administration Capacity ...................................................................................................... 23 Vaccination of Out-of-State Residents ................................................................................................ 24 3 Vaccine Prioritization and Critical Populations ............ ............. .............. ............. ............. ............. ... 24 Critical infrastructure workforce ........................................................................................................ 25 People at increased risk for severe COVID-19 illness ............. ............. ............. ............. ............ 25 People at increased risk of acquiring or transmitting COVID-19 ............. ............. ............. ... 25 People with limited access to routine vaccination services .................................................... 25 Estimates of Priority Groups ............................................................................................................... 25 Vaccination of Special and Dependent Populations.................................................................. 28 Homebound ......................................................................................................................................... 28 Long Term Cares ................................................................................................................................ 29 Custodial institutions and special populations ....................................................................... 30 American Indians ................................................................................................................................ 31 New Americans/Foreign Born/Immigrant Populations .............. ............. ............. ............. ... 32 Priority Vaccination of Infrastructure .............................................................................................. 32 Advisory Committee on COVID-19 Vaccination E thics ............ ............. ............. .............. ......... 33 Vaccine Allocation....................................................................................................................................... 34 Vaccine Ordering and Processing ......................................................................................................... 35 Physical Vaccine Management and Cold Chain ............................................................................... 36 Management of Priority Vaccine Unstable at Zero Degrees or Higher ............ ............. ..... 36 Vaccine A: ....................................................................................................................................................... 36 Vaccine B: ....................................................................................................................................................... 36 Models for Distribution of Ultra-Cold Vaccine (Vaccine A) ..................... ............. ............. . 36 Three Phase Distribution .......................................................................................................................... 37 Scenarios for Vaccine Distribution ........................................................................................................ 40 Scenario 1 Background ......................................................................................................................... 40 Vaccine A: Ultra-cold with minimum quantity of 1,000 doses only................................. 40 Phase 2: General Public Added to Phase 1 Target Populations ............. ............. ............. . 43 Scenario 2 .................................................................................................................................................. 46 Vaccine B: Frozen va ccine only with minimum quantity of 100 doses ............. ............. . 46

https://www.scribd.com/document/480713892/Covid-19-Mass-Vaccination-Plan#from_embed